Becerra-Partida EN, Patraca-Loeza AE

Language: Spanish
References: 20
Page: 42-47
PDF size: 105.82 Kb.

ABSTRACT

Introduction: Frailty is characterized by decreased strength, endurance, and physiological functions, which in addition to natural deterioration in elder population can contribute to the risk of adverse effects on their health. Objective: To determine the prevalence of frailty syndrome in adults over 70 years of age in the Family Medicine Unit (UMF) number 78, of the Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco. Material and methods: A non-analytical cross-sectional study was conducted, probabilistic sampling was carried out for convenience, which included adult patients over 70 years of age with comorbidities, who attended the family medicine consultation services at UMF No. 78, in a one month period, different previously validates instruments were applied to determine frailty syndrome data in the elderly such as the FRAIL scale, Edmonton scale and Karnofsky's functional assessment, as well as the data collection card. The corresponding statistical analysis was performed with the SPSS v.19 software. For descriptive statistics, frequencies and proportions in qualitative variables were used; in the quantitative variables mean, median, mode and standard deviation. Results: From a total sample of 372 patients, it was found that under de Edmonton scale the most frequent category was "Non-fragile" with 36.02%; according to the FRAIL scale assessment, the prevailing category was "Fragile" with 45.97%. According to Karnofsky's functional assessment, 33.06% of the patients showed a score of 70. There is a statistically significant agreement between the Edmonton and FRAIL scales. Conclusions: It is concluded that there is a high prevalence of frail older adults; this study seeks to draw attention to the importance of the evaluation of frailty in every geriatric patient, in order to detect it in time and avoid the development of dependence and disability. It is essential the intervention of the family doctor from the first consultation of the elderly in order to identify the fragility of the patient and prevent the consequences. A greater number of studies on the subject is necessary in order to know the situation of these patients.

REFERENCES

1. Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh-Manoux A et al. Measures of frailty in population-based studies: an overview. BMC Geriatrics 2013, 13: 64.

2. Ng T, Feng L, Nyunt M, Larbi A, Yap K. Frailty in older persons: multisystem risk factors and the frailty risk index (FRI). J Am Med Dir Assoc. 2014; 15 (9): 635-642.

3. Tapia C, Valdivia-Rojas Y, Varela H, Carmona A, Iturra V, Jorquera M. Indicadores de fragilidad en adultos mayores del sistema público de salud de la ciudad de Antofagasta. Rev Med Chile. 2015; 143: 459-466.

4. Sousa M, Tavares D. Factores asociados al síndrome de fragilidad en ancianos residentes en área urbana. Rev Latino-Am Enfermagem. 2014; 22 (5): 874-882.

5. Chen X, Mao G, Leng S. Frailty syndrome: an overview. Clin Interv Aging. 2014; 9: 433-441.

6. Zaslavsky O, Cochrane B, Thompson H, Woods N, Herting J, LaCroix A. Frailty: a review of the first decade of research. Biol Res Nurs. 2013; 15 (4): 422-432.

7. Yeolekar M, Sukumaran S. Frailty syndrome: a review. J Assoc Physicians India. 2014; 62 (11): 34-38.

8. Ak?n S, Maz?c?oglu M, Mucuk S, Gocer S, Deniz Safak E, Arguvanli S et al. The prevalence of frailty and related factors in community-dwelling Turkish elderly according to modified Fried Frailty Index and FRAIL scales. Aging Clin Exp Res. 2015; 27 (5): 703-709.

9. Lluis G. Fragilidad y asociaciones de riesgo en adultos mayores de una comunidad urbana. Rev Cub Med Mil. 2013; 42 (3): 368-376.

10. Sánchez-García S, Sánchez-Arenas R, García-Peña C, Rosas-Carrasco O, Ávila-Funes J, Ruiz-Arregui L et al. Frailty among community-dwelling elderly Mexican people: prevalence and association with sociodemographic characteristics, health state and the use of health services. Geriatr Gerontol Int. 2014; 14: 395-402.

11. Vaughan L, Corbin AL, Goveas JS. Depression and frailty in later life: a systematic review. Clin Interv Aging. 2015; 10: 1947-1958.

12. Mezuk B, Lohman M, Dumenci L, Lapane KL. Are depression and frailty overlapping syndromes in mid- and late-life? A latent variable analysis. Am J Geriatr Psychiatry. 2013; 21: 560-569.

13. Lohman M, Dumenci L, Mezuk B. Depression and frailty in late life: evidence for a common vulnerability. J Gerontol B Psychol Sci Soc Sci. 2016; 71 (4): 630-640.

14. Feng L, Nyunt M, Feng L, Yap K, Ng T. Frailty predicts new and persistent depressive symptoms among community-dwelling older adults: findings from Singapore longitudinal aging study. J Am Med Dir Assoc. 2014; 15: 76.e7-76.e12.

15. St John PD, Tyas SL, Montgomery PR. Depressive symptoms and frailty. Int J Geriatr Psychiatry. 2013; 28 (6): 607-614.

16. Rolland Y, Morley J. Frailty and polypharmacy. J Nutr Health Aging. 2016; 20 (6): 645-646.

17. Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A et al. Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc. 2017; 18 (7): 624-628.

18. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015; 24: 637-646.

19. Molés MP, Lavedán A, Jürschik P, Nuin C, Botigué T, Maciá L. Estudio de fragilidad en adultos mayores. Diseño metodológico. Gerokomos. 2016; 27 (1): 8-12.

20. Eyigor S, Kutsal YG, Duran E, Huner B, Paker N, Durmus B et al. Frailty prevalence and related factors in the older adult-FrailTURK project. Age (Dordr). 2015; 37 (3): 9791.